# NeuroOne Medical (NMTC) — Earnings

NMTC · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/nmtc/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.23 |
| EPS estimate | −$0.23 |
| EPS surprise | +0.00% |
| Revenue surprise | −0.40% |
| Revenue | $2.0M |
| Revenue estimate | $2.0M |
| Reported | Aug 13, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1500198/000121390026088724/ea0301141-10q_neuro.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/f4b144c8-6e8f-44ed-4820-7e845c808c23.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2026 | Aug 13, 2026 | −$0.23 | −$0.23 | 0.00% | $2.0M | $2.0M |
| Q2 2026 | May 12, 2026 | −$0.23 | −$0.25 | -10.28% | $2.6M | $2.4M |
| Q1 2026 | Feb 17, 2026 | −$0.18 | −$0.18 | 0.00% | $2.9M | $2.9M |
| Q4 2025 | Dec 17, 2025 | −$0.22 | −$0.30 | -38.12% | $2.5M | $2.7M |
| Q3 2025 | Aug 14, 2025 | −$0.30 | −$0.18 | 40.00% | $1.8M | $1.7M |
| Q2 2025 | May 13, 2025 | −$0.54 | −$0.42 | 22.22% | $1.3M | $1.4M |
| Q1 2025 | Jan 10, 2025 | −$0.60 | $0.36 | 160.00% | $2.1M | $6.3M |
| Q4 2024 | Dec 17, 2024 | −$0.54 | −$0.66 | -22.22% | $1.8M | $6.3M |
| Q3 2024 | Aug 14, 2024 | −$0.54 | −$0.60 | -11.11% | $1.5M | $825,776.00 |
| Q2 2024 | May 14, 2024 | −$0.54 | −$0.66 | -22.22% | $1.2M | $1.4M |
| Q1 2024 | Feb 13, 2024 | −$0.84 | −$0.84 | 0.00% | $850,000.00 | $977,649.00 |
| Q4 2023 | Dec 14, 2023 | −$1.05 | −$1.03 | 2.25% | $800,000.00 | $742,000.00 |
| Q3 2023 | Aug 14, 2023 | −$1.23 | −$1.20 | 2.44% | $339,500.00 | $629,906.00 |
| Q2 2023 | May 11, 2023 | −$1.23 | −$1.26 | -2.44% | $226,500.00 | $466,176.00 |
| Q4 2022 | Dec 22, 2022 | −$0.66 | −$0.48 | 27.27% | $1.8M | $2.0M |
| Q3 2022 | Aug 11, 2022 | −$1.35 | −$1.02 | 24.44% | — | — |
| Q2 2022 | May 12, 2022 | −$1.20 | −$1.14 | 5.00% | — | $18,500.00 |
| Q1 2022 | Feb 14, 2022 | −$1.11 | −$1.08 | 2.70% | — | — |
| Q4 2021 | Dec 15, 2021 | −$1.41 | −$1.08 | 23.40% | $50,000.00 | $100,000.00 |
| Q3 2021 | Aug 13, 2021 | $0.00 | −$1.50 | 0.00% | — | $100,000.00 |

## Frequently Asked Questions

### When did NeuroOne Medical (NMTC) last report earnings?

NeuroOne Medical last reported on Aug 13, 2026, covering fiscal Q3 2026.

### Did NMTC beat earnings estimates?

NeuroOne Medical reported EPS of −$0.23 for Q3 2026, in line with the −$0.23 consensus estimate.

### How much revenue did NMTC report last quarter?

NeuroOne Medical reported $2.0M in revenue for Q3 2026, against a consensus estimate of $2.0M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).